MSGNX
Price
$5.19
Change
-$0.01 (-0.19%)
Updated
Sep 11 closing price
Net Assets
681.06M
VISGX
Price
$95.80
Change
+$0.82 (+0.86%)
Updated
Sep 11 closing price
Net Assets
44.71B
Interact to see
Advertisement

MSGNX vs VISGX

MSGNX vs VISGX Comparison Chart in %
View a ticker or compare two or three
VS
MSGNX vs. VISGX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSGNX is a Hold and VISGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 44.7B vs. MSGNX (681M). VISGX pays higher dividends than MSGNX: VISGX (0.32) vs MSGNX (0.00). MSGNX was incepted earlier than VISGX: MSGNX (24 years) vs VISGX (28 years). MSGNX (1.58) is less costly to investors than VISGX (0.19). MSGNX is a more actively managed with annual turnover of: 76.00 vs. VISGX (24.00). MSGNX (0) and VISGX (0) have matching initial minimum investment requirements. VISGX annual gain was more profitable for investors over the last year : 12.25 vs. MSGNX (-24.52). VISGX return over 5 years is better than : 17.36 vs. MSGNX (-57.27).
MSGNXVISGXMSGNX / VISGX
Total Expense Ratio1.550.19816%
Annual Report Gross Expense Ratio1.580.19832%
Fund Existence24 years28 years-
Gain YTD17.89011.959150%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets681M44.7B2%
Annual Yield % from dividends0.000.32-
Returns for 1 year-24.5212.25-200%
Returns for 3 years-12.4450.95-24%
Returns for 5 years-57.2717.36-330%
Returns for 10 years-44.36167.12-27%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHSAX63.02N/A
N/A
BlackRock Health Sciences Opps Inv A
MDFOX6.73N/A
N/A
BlackRock Large Cap Focus Growth Inv A
MSACX22.35N/A
N/A
Morgan Stanley Inst Passport ovrs eq I
RYAKX77.62N/A
N/A
Rydex Russell 2000 1.5x Strategy A
VCGRX22.56N/A
N/A
Virtus KAR Capital Growth R6